Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ZOGENIX, INC. | 9,923,335 | reported | 16 Sept 2011 | tx 20+10,102,586−4,252,587 |
| Regado Biosciences Inc | 3,553,322 | reported | 04 May 2015 | tx 16+2,827,886−1,800,109 |
| Aldeyra Therapeutics, Inc. | 1,973,389 | reported | 07 May 2014 | tx 11+2,051,515−1,440,857 |
| TRANZYME INC | 1,897,336 | reported | 15 Jul 2013 | tx 6+2,654,982 |
| Volcano CORP | 1,868,540 | reported | 16 Jul 2008 | tx 37+10,124,227−16,416,908 |
| Otonomy, Inc. | 1,548,792 | reported | 18 Aug 2014 | tx 7+1,616,547−1,653,771 |
| Evoke Pharma Inc | 1,114,327 | reported | 30 Sept 2013 | tx 4+1,133,333−1,133,333 |
| Orexigen Therapeutics, Inc. | 461,265 | reported | 22 Dec 2011 | tx 56+7,925,133−4,684,807 |
| ACHILLION PHARMACEUTICALS INC | 159,896 | reported | 18 Jan 2013 | tx 5+184,896−2,200,000 |
| REVA Medical, Inc. | 85,186 | reported | 23 Mar 2012 | tx 44+5,489,470−5,239,011 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2015 | PURCHASE | Regado Biosciences Inc | 277,777 | 10.62 USD | |
| 25 Nov 2014 | EXERCISE | Neothetics, Inc. | 1,570 | 8.54 USD | |
| 25 Nov 2014 | TAX_WITHHOLDING | Neothetics, Inc. | 1,725 | 14.00 USD | |
| 25 Nov 2014 | EXERCISE | Neothetics, Inc. | 2,827 | 8.54 USD | |
| 25 Nov 2014 | TAX_WITHHOLDING | Neothetics, Inc. | 958 | 14.00 USD | |
| 25 Nov 2014 | CONVERSION | Neothetics, Inc. | 46,309 | — | |
| 25 Nov 2014 | EXERCISE | Neothetics, Inc. | 1,570 | 0.00 USD | deriv |
| 25 Nov 2014 | CONVERSION | Neothetics, Inc. | 102,282 | 0.00 USD | deriv |
| 25 Nov 2014 | CONVERSION | Neothetics, Inc. | 36,913 | 0.00 USD | deriv |
| 25 Nov 2014 | CONVERSION | Neothetics, Inc. | 104,247 | 0.00 USD | deriv |
| 25 Nov 2014 | CONVERSION | Neothetics, Inc. | 12,578 | 0.00 USD | deriv |
| 25 Nov 2014 | EXERCISE | Neothetics, Inc. | 2,827 | 0.00 USD | deriv |
| 17 Nov 2014 | OTHER | Durata Therapeutics, Inc. | 22,306 | — | |
| 21 Oct 2014 | PURCHASE | Atara Biotherapeutics, Inc. | 248,159 | 11.00 USD | first after silence |
| 21 Oct 2014 | CONVERSION | Atara Biotherapeutics, Inc. | 1,893,383 | — | |
| 21 Oct 2014 | CONVERSION | Atara Biotherapeutics, Inc. | 1,272,607 | 0.00 USD | deriv |
| 21 Oct 2014 | CONVERSION | Atara Biotherapeutics, Inc. | 620,776 | 0.00 USD | deriv |
| 18 Aug 2014 | CONVERSION | Otonomy, Inc. | 1,548,792 | 0.00 USD | |
| 18 Aug 2014 | EXERCISE | Otonomy, Inc. | 67,755 | 8.79 USD | |
| 18 Aug 2014 | TAX_WITHHOLDING | Otonomy, Inc. | 37,224 | 16.00 USD | |
| 18 Aug 2014 | CONVERSION | Otonomy, Inc. | 436,485 | 0.00 USD | deriv |
| 18 Aug 2014 | CONVERSION | Otonomy, Inc. | 925,479 | 0.00 USD | deriv |
| 18 Aug 2014 | EXERCISE | Otonomy, Inc. | 67,755 | 0.00 USD | deriv |
| 18 Aug 2014 | TAX_WITHHOLDING | Otonomy, Inc. | 186,828 | 0.00 USD | deriv |
| 07 May 2014 | CONVERSION | Aldeyra Therapeutics, Inc. | 21,250 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 21 Oct 2014.